{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:40:12Z","timestamp":1790232012051,"version":"4.1.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gicoConselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico (CNPq)","award":["406148\/2016-3"],"award-info":[{"award-number":["406148\/2016-3"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.cyto.2019.04.008","type":"journal-article","created":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T16:41:16Z","timestamp":1556728876000},"page":"92-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Interleukin-17 expression in the serum and exfoliated cervical cells of patients infected with high-risk oncogenic human papillomavirus"],"prefix":"10.1016","volume":"120","author":[{"given":"Camila","family":"Mareti Bonin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa","family":"Zatorre Almeida-Lugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrielli","family":"Rodrigues dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cacilda","family":"Tezelli Junqueira Padovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Fl\u00e1via","family":"Silva Pina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alda Maria","family":"Teixeira Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Eurico","family":"dos Santos Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00falio C\u00e9sar","family":"Possati Resende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriane Cristina","family":"Bovo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00eas Aparecida","family":"Tozetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2019.04.008_b0005","doi-asserted-by":"crossref","first-page":"5445","DOI":"10.4049\/jimmunol.150.12.5445","article-title":"CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene","volume":"150","author":"Rouvier","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2019.04.008_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1189\/jlb.71.1.1","article-title":"IL-17: prototype member of an emerging cytokine family","volume":"71","author":"Aggarwal","year":"2002","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cyto.2019.04.008_b0015","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.jaci.2004.10.019","article-title":"IL-17 cytokine family","volume":"114","author":"Kawaguchi","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cyto.2019.04.008_b0020","doi-asserted-by":"crossref","first-page":"5494","DOI":"10.4049\/jimmunol.0901000","article-title":"Phenotypical characterization of human Th17 cells unambiguously identified by surface IL-17A expression","volume":"183","author":"Brucklacher-Waldert","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2019.04.008_b0025","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/nature07036","article-title":"Induction and effector functions of T(H)17 cells","volume":"453","author":"Bettelli","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2019.04.008_b0030","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.4049\/jimmunol.177.7.4662","article-title":"IL-17 production is dominated by cd T cells rather than CD4 T cells during Mycobacterium tuberculosis infection","volume":"177","author":"Lockhart","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2019.04.008_b0035","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nri2800","article-title":"Innate IL-17-producing cells: the sentinels of the immune system","volume":"10","author":"Cua","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cyto.2019.04.008_b0040","doi-asserted-by":"crossref","first-page":"5296","DOI":"10.4049\/jimmunol.0900036","article-title":"IL-23 drives pathogenic IL-17-producing CD8+ T cells","volume":"182","author":"Ciric","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2019.04.008_b0045","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.4049\/jimmunol.170.4.2106","article-title":"IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide- induced airway neutrophilia: IL-15 as a possible trigger","volume":"170","author":"Ferretti","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2019.04.008_b0050","doi-asserted-by":"crossref","first-page":"e24048","DOI":"10.1371\/journal.pone.0024048","article-title":"Il-17A expression is localised to both mononuclear and polymorphonuclear synovial cell infiltrates","volume":"6","author":"Moran","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.cyto.2019.04.008_b0055","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.4049\/jimmunol.0901843","article-title":"Sehy D, Stumhofer JS, Hunter CA.IL-6 promotes NK cell production of IL-17 during toxoplasmosis","volume":"184","author":"Passos","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2019.04.008_b0060","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1084\/jem.20061551","article-title":"Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia","volume":"204","author":"Michel","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2019.04.008_b0065","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1128\/IAI.73.2.935-943.2005","article-title":"Cytokine profiling of macrophages exposed to Porphyromonas gingivalis, its lipopolysaccharide, or its FimA protein","volume":"73","author":"Zhou","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cyto.2019.04.008_b0070","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nri3365","article-title":"Innate lymphoid cells\u2013a proposal for uniform nomenclature","volume":"13","author":"Spits","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cyto.2019.04.008_b0075","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.4049\/jimmunol.160.7.3513","article-title":"IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages","volume":"160","author":"Jovanovic","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2019.04.008_b0080","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1084\/jem.194.4.519","article-title":"Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense","volume":"194","author":"Ye","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2019.04.008_b0085","doi-asserted-by":"crossref","first-page":"H3356","DOI":"10.1152\/ajpheart.00928.2007","article-title":"IL-17 stimulates mmp-1 expression in primary human cardiac fibroblasts via p38 mapk- and erk1\/2-dependent c\/ebp-beta, nf-kappab, and ap-1 activation","volume":"293","author":"Cortez","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.cyto.2019.04.008_b0090","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1002\/eji.200838535","article-title":"Induction, function and regulation of IL-17-producing T cells","volume":"38","author":"Mills","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cyto.2019.04.008_b0095","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1182\/blood-2002-05-1461","article-title":"Interleukin-17 promotes angiogenesis and tumor growth","volume":"101","author":"Numasaki","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2019.04.008_b0100","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.imlet.2004.01.014","article-title":"Interleukin-17 augments tumor necrosis factor-\u03b1-induced elaboration of proangiogenic factors from fibroblasts","volume":"93","author":"Numasaki","year":"2004","journal-title":"Immunol. Lett."},{"issue":"59","key":"10.1016\/j.cyto.2019.04.008_b0105","first-page":"3698","article-title":"Interleukin 17, a T-cell derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice","volume":"1999","author":"Tartour","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.cyto.2019.04.008_b0110","first-page":"1271","article-title":"Tumor-infiltrating CD4+Th17 cells produce IL-17 in tumor microenvironment and promote tumor progression in human gastric cancer","volume":"25","author":"Iida","year":"2011","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.cyto.2019.04.008_b0115","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.bbrc.2011.03.021","article-title":"IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma","volume":"407","author":"Liu","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cyto.2019.04.008_b0120","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.jhep.2008.12.033","article-title":"Increased intratumoral IL-17- producing cells correlate with poor survival in hepatocellular carcinoma patients","volume":"50","author":"Zhang","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cyto.2019.04.008_b0125","doi-asserted-by":"crossref","first-page":"7424","DOI":"10.3390\/ijms12117424","article-title":"Distribution and clinical significance of TH17 cells in the tumor microenvironment and peripheral blood of pancreatic cancer patients","volume":"12","author":"He","year":"2011","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cyto.2019.04.008_b0130","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1746-1596-8-61","article-title":"The Th17\/Treg balance and the expression of related cytokines in Uygur cervical cancer patients","volume":"8","author":"Chen","year":"2013","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.cyto.2019.04.008_b0135","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.cca.2011.01.015","article-title":"The imbalance of TH17\/treg in patients with uterine cervical cancer","volume":"412","author":"Zhang","year":"2011","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cyto.2019.04.008_b0140","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.bbrc.2008.07.060","article-title":"The prevalence of Th17 cells in patients with gastric cancer","volume":"374","author":"Zhang","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cyto.2019.04.008_b0145","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1006\/bbrc.2001.4618","article-title":"Expression of IL- 17 mRNA in ovarian cancer","volume":"282","author":"Kato","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cyto.2019.04.008_b0150","doi-asserted-by":"crossref","first-page":"R95","DOI":"10.1186\/bcr2195","article-title":"IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines","volume":"10","author":"Zhu","year":"2008","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.cyto.2019.04.008_b0155","unstructured":"L. Bruni, L. Barrionuevo-Rosas, G. Albero, B. Serrano, M. Mena, D. G\u00f3mez, J. Mu\u00f1oz, F.X. Bosch, S. de Sanjos\u00e9, ICO Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in the World. Summary Report 27 July 2017 (August 23th, 2018)."},{"issue":"Suppl 7","key":"10.1016\/j.cyto.2019.04.008_b0160","doi-asserted-by":"crossref","first-page":"H1","DOI":"10.1016\/j.vaccine.2013.10.003","article-title":"Comprehensive control of human papillomavirus infections and related diseases","volume":"31","author":"Bosch","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.cyto.2019.04.008_b0165","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","article-title":"Human papillomavirus and cervical cancer","volume":"370","author":"Schiffman","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2019.04.008_b0170","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.1038\/ncomms6317","article-title":"Clearance of persistent hpv infection and cervical lesion by therapeutic dna vaccine in cin3 patients","volume":"5","author":"Kim","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cyto.2019.04.008_b0175","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12967-015-0498-9","article-title":"Cell mediated immunity against hpv16 e2, e6 and e7 peptides in women with incident cin and in constantly hpv-negative women followed-up for 10-years","volume":"13","author":"Paaso","year":"2015","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.cyto.2019.04.008_b0180","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/cam4.1279","article-title":"Effects of Th17 cells and IL-17 in the progression of cervical carcinogenesis with high-risk human papillomavirus infection","volume":"7","author":"Xue","year":"2018","journal-title":"Cancer Med."},{"key":"10.1016\/j.cyto.2019.04.008_b0185","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejogrb.2007.06.015","article-title":"Murta EF. Local profile of cytokines and nitric oxide in patients with bacterial vaginosis and cervical intraepithelial neoplasia","volume":"138","author":"Tavares-Murta","year":"2008","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.cyto.2019.04.008_b0190","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.cyto.2011.09.012","article-title":"Differences in the concentration and correlation of cervical immune markers among HPV positive and negative perimenopausal women","volume":"56","author":"Marks","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2019.04.008_b0195","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s10147-014-0680-8","article-title":"Cytokine profile in cervical mucosa of japanese patients with cervical intraepithelial neoplasia","volume":"20","author":"Iwata","year":"2015","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.cyto.2019.04.008_b0200","article-title":"Detection of regulatory T cell phenotypic markers and cytokines in patients with human papillomavirus infection","author":"Bonin","year":"2018","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.cyto.2019.04.008_b0205","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1128\/JCM.38.1.357-361.2000","article-title":"Improved amplification of genital human papillomaviruses","volume":"38","author":"Gravitt","year":"2000","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.cyto.2019.04.008_b0210","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1001\/jama.1991.03460040048027","article-title":"Genital human papillomavirus infection in female university students as determined by a PCR based method","volume":"265","author":"Bauer","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.cyto.2019.04.008_b0215","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/modpathol.3800737","article-title":"Distribution and viral load of eight oncogenic types of human papillomavirus (HPV) and HPV 16 integration status in cervical intraepithelial neoplasia and carcinoma","volume":"20","author":"Guo","year":"2007","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.cyto.2019.04.008_b0220","doi-asserted-by":"crossref","first-page":"167","DOI":"10.32635\/2176-9745.RBC.2003v49n3.2093","article-title":"Genotipagem de Papiloma V\u00edrus Humano em paciente com papilomatose lar\u00edngea recorrente","volume":"49","author":"Silva","year":"2003","journal-title":"Rev. Bras. Cancerol."},{"key":"10.1016\/j.cyto.2019.04.008_b0225","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jcv.2007.11.021","article-title":"Complete genotyping of mucosal human papillomavirus using a restriction fragment length polymorphism analysis and an original typing algorithm","volume":"42","author":"Nobre","year":"2008","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.cyto.2019.04.008_b0230","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1128\/jcm.35.6.1304-1310.1997","article-title":"PCR detection of human papillomavirus: comparison between my09\/my11 and gp5+\/gp6+ primer systems","volume":"35","author":"Qu","year":"1997","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.cyto.2019.04.008_b0235","first-page":"819","article-title":"Trichomonas vaginalis: repeated DNA target for highly sensitive and specific polymerase chain reaction diagnosis","volume":"40","author":"Kengne","year":"1994","journal-title":"Cell Mol. Biol. (Noisy-le-grand)"},{"key":"10.1016\/j.cyto.2019.04.008_b0240","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1590\/S1413-86702003000200001","article-title":"Detection of Chlamydia trachomatis in endocervical smears of sexually active women in Manaus-AM, Brazil, by PCR","volume":"7","author":"Santos","year":"2003","journal-title":"Braz. J. Infect. Dis."},{"key":"10.1016\/j.cyto.2019.04.008_b0245","first-page":"291","article-title":"Quantification of histochemical staining by color deconvolution","volume":"23","author":"Ruifrok","year":"2001","journal-title":"Anal. Quant. Cytol. Histol."},{"key":"10.1016\/j.cyto.2019.04.008_b0250","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/imm.12487","article-title":"Local immunosuppression induced by high viral load of human papillomavirus: characterization of cellular phenotypes producing interleukin-10 in cervical neoplastic lesions","volume":"146","author":"Prata","year":"2015","journal-title":"Immunology"},{"issue":"7","key":"10.1016\/j.cyto.2019.04.008_b0255","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJM199802123380703","article-title":"Natural history of cervicovaginal papillomavirus infection in young women","volume":"338","author":"Ho","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cyto.2019.04.008_b0260","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0002-9343(97)00181-2","article-title":"Therapeutic approaches to genital warts","volume":"102","author":"Beutner","year":"1997","journal-title":"Am. J. Med."},{"key":"10.1016\/j.cyto.2019.04.008_b0265","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/(SICI)1097-0215(19980209)75:4<546::AID-IJC9>3.0.CO;2-T","article-title":"The viral origin of cervical cancer in Rabat, Morocco","volume":"75","author":"Chaouki","year":"1998","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.cyto.2019.04.008_b0270","unstructured":"International agency for research on cancer (IARC), IARC Working Group on the Evaluation of Carcinogenic Risk to Humans, Biological Agents. Lyon (FR): International Agency for Research on Cancer; 2012. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 100B.) Human Papillomaviruses. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK304347\/."},{"key":"10.1016\/j.cyto.2019.04.008_b0275","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0891-5520(20)30624-3","article-title":"Human papillomaviruses","volume":"8","author":"Mccance","year":"1994","journal-title":"Infect. Dis. Clin. North Am."},{"key":"10.1016\/j.cyto.2019.04.008_b0280","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ijc.25396","article-title":"Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication","volume":"128","author":"Li","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.cyto.2019.04.008_b0285","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Retrospective international survey and HPV time trends study group. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"De Sanjos\u00e9","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.cyto.2019.04.008_b0290","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/00006250-199203000-00002","article-title":"Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types","volume":"79","author":"Lorincz","year":"1992","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.cyto.2019.04.008_b0295","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1750-9378-6-20","article-title":"Distribution of hpv genotypes in cervical intraepithelial lesions and cervical cancer in tanzanian women","volume":"6","author":"Vidal","year":"2011","journal-title":"Infect Agent Cancer"},{"key":"10.1016\/j.cyto.2019.04.008_b0300","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1002\/cncr.28038","article-title":"Individual and geographic disparities in human papillomavirus types 16\/18 in high-grade cervical lesions: associations with race, ethnicity, and poverty","volume":"119","author":"Niccolai","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.cyto.2019.04.008_b0305","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Mu\u00f1oz","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cyto.2019.04.008_b0310","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/jnci\/92.18.1500","article-title":"Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome","volume":"92","author":"Frisch","year":"2000","journal-title":"J. Natl Cancer Inst."},{"key":"10.1016\/j.cyto.2019.04.008_b0315","first-page":"217","article-title":"Immune response to human papillomaviruses and the prospects for human papillomavirus-specific immunisation","volume":"186","author":"Tindle","year":"1994","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.cyto.2019.04.008_b0320","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1600-065X.2010.00966.x","article-title":"Regulation of immune responses to HPV infection and during HPV-directed immunotherapy","volume":"239","author":"Bhat","year":"2011","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cyto.2019.04.008_b0325","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1084\/jem.20082030","article-title":"TH17 cells enhance viral persistence and inhibit t cell cytotoxicity in a model of chronic virus infection","volume":"206","author":"Hou","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2019.04.008_b0330","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.4049\/jimmunol.1400216","article-title":"IL-17 suppresses immune effector functions in human papillomavirus-associated epithelial hyperplasia","volume":"193","author":"Gosmann","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2019.04.008_b0335","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.4049\/jimmunol.178.5.3186","article-title":"TLR9 expression and function is abolished by the cervical cancerassociated human papillomavirus type 16","volume":"178","author":"Hasan","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2019.04.008_b0340","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/sj.onc.1205008","article-title":"Down-regulation of MHC class I by bovine papillomavirus E5 oncoproteins","volume":"21","author":"Ashrafi","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.cyto.2019.04.008_b0345","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1600-065X.1999.tb01288.x","article-title":"Potential strategies utilized by papillomavirus to evade host immunity","volume":"168","author":"Frazer","year":"1999","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cyto.2019.04.008_b0350","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13027-015-0005-1","article-title":"IL-10, IL-15, IL-17, and, GMCSF levels in cervical cancer tissue of tanzanian women infected with HPV16\/18 VS. non-HPV16\/18 genotypes","volume":"10","author":"Vidal","year":"2015","journal-title":"Infect Agent Cancer"},{"key":"10.1016\/j.cyto.2019.04.008_b0355","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.imlet.2012.11.002","article-title":"Anti-cancer versus cancer-promoting effects of the interleukin-17-producing T helper cells","volume":"149","author":"Hemdan","year":"2013","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.cyto.2019.04.008_b0360","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.4049\/jimmunol.0901017","article-title":"Protumor vs antitumor functions of il-17","volume":"183","author":"Murugaiyan","year":"2009","journal-title":"J. Immunol."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104346661930105X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104346661930105X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:53:26Z","timestamp":1760907206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104346661930105X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":72,"alternative-id":["S104346661930105X"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2019.04.008","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin-17 expression in the serum and exfoliated cervical cells of patients infected with high-risk oncogenic human papillomavirus","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2019.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}